FDA Inspection 1022665 — Prof. Shmuel Banai
The FDA completed an inspection of Prof. Shmuel Banai on July 12, 2017 in Tel Aviv. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 12, 2017
- Fiscal Year
- 2017
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Tel Aviv (Israel)
Additional Details
Clinical Investigator (CI)